4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-002778
Chief Executive Officer gave up 165,178 shares (to pay taxes)
- Chief Executive Officer acquired 783,694 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2019-01-06 | Grant or award | +337,266 | 1,518,075 | D | ||
| Cooper Laurence James Neil Chief Executive Officer | 2019-01-06 | Grant or award | +446,428 | 1,964,503 | D | ||
| Cooper Laurence James Neil Chief Executive Officer | 2019-01-06 | Shares withheld for taxes | −165,178 | $2.24 | $369,999 | 1,799,325 | D |
| Derivatives | |||||||
| Cooper Laurence James Neil Chief Executive Officer | 2019-01-06 | Grant or award · Employee Stock Option (right to buy) | +531,813 | 531,813 | D | ||
Loading xslF345X03/doc4.xml…